EYE DROPS Russian patent published in 2012 - IPC A61K9/08 A61P27/02 

FIELD: medicine.

SUBSTANCE: invention refers to pharmaceutical industry, namely to drugs presented in the form of a solution and applicable for therapeutic purposes, particularly treating eye diseases. Eye drops for inflammatory eye diseases characterised by the fact that they contain benzalkonium chloride, sodium hydrogen phosphate dodecahydrate, disodium edetate, sodium chloride, sodium hyaluronate, potassium dihydrogen phosphate, Polysorbate, linden blossom infusion, camomile blossom infusion, water for injections in certain proportions and pH 4.5-11.4.

EFFECT: eye drops provide deposition, uniform absorption of the active ingredients over a period of time between installations, eye tissue tolerance and finally substantially expanded possibility of therapeutic application; besides, prolonged action of an antihistaminic preparation and a vasoconstrictive agent and availability of a hypoallergic preservative are ensured.

3 ex